Nurse Pract. 2024 May 1;49(5):34-39. doi: 10.1097/01.NPR.0000000000000175.
The COVID-19 pandemic resulted in decreased access to routine diabetes care in rural areas and adversely affected self-management of diabetes.
This article describes a descriptive pretest-posttest study conducted to assess efficacy in managing hemoglobin A1C (A1C) among patients with type 2 diabetes mellitus (T2DM) using a continuous glucose monitoring (CGM) system for 1 year.
A total of 14 participants completed the Diabetes Mellitus Self-Efficacy Scale survey. Of those 14, 11 used CGM for 1 year; of the 11 who maintained CGM use, A1C levels improved in 9.
Results indicate that CGM combined with medication management positively impacts self-efficacy in managing A1C levels among patients with T2DM. Interdisciplinary collaboration optimizes patient outcomes.
COVID-19 大流行导致农村地区常规糖尿病护理的可及性降低，并对糖尿病的自我管理产生不利影响。
本文描述了一项描述性的预试验后试验研究，该研究旨在评估使用连续血糖监测 (CGM) 系统对 1 型糖尿病患者进行 1 年的血红蛋白 A1C (A1C) 管理的疗效。
共有 14 名参与者完成了糖尿病自我效能量表调查。在这 14 人中，有 11 人使用 CGM 长达 1 年；在维持 CGM 使用的 11 人中，有 9 人的 A1C 水平有所改善。
结果表明，CGM 与药物管理相结合，可积极影响 2 型糖尿病患者管理 A1C 水平的自我效能。跨学科合作可优化患者的治疗效果。
